Trade LAB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Standard BioTools Inc. (LAB) is trading at US$0.65, down 0.61% today as of Aug 28, 10:57 EDT. The company has a market capitalisation of US$262.64M. Over the past 52 weeks, LAB has traded between US$0.63 and US$1.72. On Syfe you can trade LAB with $0 commission and add it to your watchlist.
| Previous close | US$0.65 |
|---|---|
| Market cap | US$262.64M |
| 52-week range | US$0.63 – US$1.72 |
| Volume | 1.49M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Standard BioTools Inc.
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.
Year: 2011
Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences
Jul 28, 2:26 PM · MT Newswires
Standard BioTools, Treeline Biosciences to Merge in All-Stock Deal
Jun 8, 12:06 PM · MT Newswires
Standard BioTools Regains Compliance With Nasdaq's Minimum Bid Price Requirement
Jun 8, 10:23 AM · MT Newswires
Standard BioTools Inc. (LAB) stock is trading at US$0.65, -0.61% from the previous close of US$0.65.
The market cap for Standard BioTools Inc. (LAB) stock is approximately US$262.64M.
The 52-week high for Standard BioTools Inc. (LAB) stock is US$1.72.
The 52-week low for Standard BioTools Inc. (LAB) stock is US$0.63.
Standard BioTools Inc. (LAB) does not currently pay a dividend.
Stay on top of LAB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
